Insulet | الأصول





الأصول تغيير تاريخ
Abbott USD 86.71B 2.53B 2025-12
Align Technology USD 6.23B 141K 2025-12
AtriCure USD 654.18M 18.74M 2025-12
Avanos Medical USD 1.07B 6M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Cardinal Health USD 58.08B 2.86B 2025-12
Cooper Companies USD 12.39B 18.1M 2025-09
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Eli Lilly USD 112.48B 2.46B 2025-12
Globus Medical USD 5.3B 207.12M 2025-12
ICU Medical USD 4.05B 52.39M 2025-12
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.65B 21.45M 2025-09
J&J USD 199.21B 6.39B 2025-12
Masimo USD 1.82B 585.1M 2025-09
Medtronic USD 91.35B 374M 2025-09
Merit Medical Systems USD 2.63B 44.95M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Solventum Corp USD 13.97B 1.1B 2025-09
Stryker USD 47.84B 787M 2025-12
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 7.87B 496.72M 2025-09
West Pharmaceutical Services USD 4.27B 164.2M 2025-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12


Insulet الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.